Biosensors & POCT– category –
-
POCT Innovations Accelerate at MEDICA 2026: Biosensors, Imaging AI, and Lab-on-a-Chip Drive Precision Medicine
MEDICA Germany Overview MEDICA 2026 highlights significant advancements in Point-of-Care Testing (POCT), accelerating on-site diagnostics for rapid clinical decision-making. Progress in biosensors, imaging AI, biomarkers, and lab-on-a-ch... -
Wellness CGMs Under Scrutiny: Long-Term Benefits for Non-Diabetics Lack Robust Clinical Evidence
The European Sting Belgium Overview A recent systematic review in the Journal of Medical Internet Research questions the long-term clinical efficacy of continuous glucose monitors (CGMs) for non-diabetics. While CGMs show promise in prom... -
MIT’s Non-Invasive Raman-Based CGM Achieves Accuracy Comparable to Commercial Devices, Signaling Next-Generation Glucose Monitoring Potential
Morld USA Overview MIT researchers have developed a novel Raman-based non-invasive continuous glucose monitoring (CGM) device that reads glucose through the skin without needles. Initial tests demonstrate accuracy comparable to existing ... -
Medtronic Launches Simplera Sync CGM Sensor in South Korea, Streamlining Glucose Management for MiniMed 780G Users
KBR South Korea Overview Medtronic has launched its Simplera Sync Sensor, a new continuous glucose monitoring (CGM) device, in South Korea for users of the MiniMed 780G automated insulin delivery (AID) system. This all-in-one disposable ... -
Dexcom Expands Beyond Diabetes Sensors to Comprehensive Health Platform with G8 Launch, Stelo Introduction, and FDA TEMPO Program Inclusion
Libre Life USA Overview Dexcom is transforming from a diabetes sensor manufacturer into a broader connected health platform, marked by the announcement of its next-gen G8 CGM, a 15-day wear extension for G7 internationally, and the launc... -
Biosensors & POCT Weekly Report August 2, 2026
▼ ▼ ▼ If the infographic makes you want to read the full report, please click the download button below. ▼ ▼ ▼ 📄 Weekly Report August 02, 2026 (PDF) — Download Weekly Report August 02, 2026 (PDF) — DownloadDownload 🎙 Podcast August 02, ... -
Biosphere CRO Identifies 2026 Clinical Trial Trends: AI, Wearable Biosensors Accelerate Drug Development
Biosphere CRO International Overview Biosphere CRO reports that 2026 clinical trials are being transformed by the maturation of AI, remote monitoring infrastructure, wearable biosensors, and cloud-native data platforms. These technologie... -
Lumos Diagnostics Partners with Alpha Medical for Exclusive Romanian Distribution of FebriDx Rapid Respiratory Infection Test, Boosting European Expansion
MarketScreener Australia Overview Lumos Diagnostics Holdings has announced an exclusive distribution agreement with Romania's Alpha Medical for the commercialization of its FebriDx rapid respiratory infection POCT diagnostic test across ... -
Cambridge Researchers Integrate Functional Electronics on Biodegradable Textile Substrates, Paving Way for Sustainable Wearables
Cambridge Centre for Circular Economy UK Overview Researchers at the University of Cambridge have demonstrated the capability to embed functional electronic components directly onto textile substrates, marking a significant advance in bi... -
FDA Clears Dexcom’s Stelo Glucose Biosensor System as First OTC Continuous Glucose Monitor for Non-Insulin-Using Children Ages 2+
Weence.com USA Overview On June 12, 2026, the FDA approved Dexcom's Stelo Glucose Biosensor System as the first over-the-counter (OTC) continuous glucose monitor (CGM) for children aged 2 and older who do not use insulin. This system, wh...
